CNBC Fast Money — Episode Summary

Episode: Coreweave Reports Results… And A Would You Rather Retail Edition
Date: November 10, 2025
Host: Melissa Lee
Panel: Tim Seymour, Karen Finerman, Dan Nathan, Guy Adami, (with guest contributions by David Zervos, Emily Wilkins, Christina Parts Nevels, Ed Meyers)

Episode Overview

This lively Fast Money episode dissects the day’s tech-driven market rebound, delivers deep analysis of CoreWeave’s latest earnings, and contrasts titans in retail with a “Would You Rather?” face-off: Walmart vs. Target. It also covers the biggest headlines in weight-loss pharma, sports betting integrity, streaming giants, and the evolving AI/capex landscape. Notable guests and sharp banter highlight actionable insights and lingering risks for investors as the market heads into the year-end stretch.

Key Discussion Points & Insights

Tech’s Rebound and Macro Tailwinds

• The NASDAQ surged over 2%, led by powerhouses like Palantir, Nvidia, Broadcom, AMD, Google, and Microsoft (which snapped an 8-day skid).
• The “Mag 7” (the seven biggest US tech companies) added nearly $600 billion in market cap in one day, rekindling optimism as hopes rose for an end to the government shutdown.
• The panel speculated whether renewed risk appetite was justified and pondered the sustainability of these gains.

Quote:

“The Mag 7 names added nearly $600 billion in market cap just today.”
—Melissa Lee (00:50)

CoreWeave Earnings: Hype Meets Power Problems

• Backlog: Contracted backlog exploded to $55B, up from $30B in Q2, driven by deals with Meta ($14B), OpenAI ($6.5B), and an Nvidia-backed backstop ($6B).
• Profitability/margins: Despite revenue outperformance, operating margins came in lower than expected; gross margin was also questioned.
• Stock Reaction: The stock dropped 1.5% on the day, with overhang from a prior 28% decline in the quarter, despite impressive backlog.
• Power Infrastructure as bottleneck: Delays at third-party data centers (“power shells”) are pushing revenue into future quarters; CEO insists power is available, but the grid/power delivery logistics are the chokepoint.
• Valuation & sustainability: Panelists debated whether CoreWeave’s premium is justified, given power constraints and margin compression, suggesting more clarity is needed from management.

Memorable quotes:

“Even their older chips for Nvidia…sold out. So if anybody’s worried, even Hopper has incredible demand.”
—Christina Parts Nevels (02:08)

“Power is something I think we’re underestimating the impact that it’s going to have on a lot of these names in the build out.”
—Christina Parts Nevels (05:14)

“If Satya Nadella is telling you they can’t get enough power and this CEO is telling you they got enough power, I think I’m gonna go with Satya.”
—David Zervos (45:21)

CoreWeave Update Segment:

• Third-party datacenter delays will push Q4 revenue into Q1, though contract value is retained. Capex also dipped due to these supply chain issues.

Quote:

“It’s frustrating to deal with, quote, systemic challenges within supply chains. But…there is plenty of power for the next couple of years… The challenge is the power shell.”
—Christina Parts Nevels (37:46)

Timestamps:

• Major earnings breakdown: [02:08–05:40], update at [36:55]
• Power as industry bottleneck: [05:14–05:40], [06:09]

The AI Trade, CapEx, and Labor Market

• AI spend dominates GDP growth: The group questioned whether massive capex by hyperscalers and core tech firms is prudent, cautioning about future commoditization and the social impact of rapid automation.
• Labor market warnings: Dollar growth is driven by productivity gains, not job creation. Data revisions have shown job growth is weaker than believed—raising concerns about Main Street’s participation in the boom.
• Market breadth: While “Mag 7” dominates, healthy market leadership is preferable to “everyone winning equally.”

Quotes:

“This is not a strong labor market driven growth. This is a productivity story. And that’s the thing that’s getting me a little nervous.”
—David Zervos (16:42)

“I love the idea of leaders. I don’t think we want an S&P that has 500 stocks all up 14%... I want bankruptcies!”
—David Zervos (18:25)

“90% of GDP growth year-over-year is from this spend…It’s all like one big thing…”
—Dan Nathan (19:08)

Timestamps:

• AI/Labor mark commentary: [16:42–21:19], [22:20–24:10]

Retail “Would You Rather”: Walmart vs. Target (vs. Amazon)

• Walmart: “Expensive, but winning,” lauded for its execution, leadership in value, and outperformance.
• Target: “Cheap, sentiment is disastrous, but management finally seems to have urgency.” Seen as a contrarian value play for the next 12 months.
• Amazon: Several traders chose Amazon for its high-margin cloud and ad businesses, but when restricted to Walmart vs. Target, the panel was split with a slight tilt towards Walmart for stability but an argument for Target’s relative value.
• Market expects Walmart solid, but the low expectations bar means Target could see a positive surprise if results are “better than feared”.

Quotes:

“If you want to tell me what’s a more attractive stock today, it’s the one that trades at 11 and a half times forward…Target is a lot more interesting even though Walmart’s a better company over the next 12 months.”
—Tim Seymour (35:56)

“There’s a reason why Target has been underperforming now for four years…Walmart on the other hand has done everything right.”
—Dan Nathan (35:25)

Timestamps:

• Full segment: [34:14–36:33]

Pharma/Weight Loss: Pfizer, Lilly, Novo Nordisk

• Pfizer wins $10B bid for Medcera, beating Novo Nordisk. Medcera doesn’t have drugs on the market; shares dropped.
• Lilly gets analyst upgrade—access via Medicare/Medicaid to fuel next wave of growth.
• Panel noted Lilly’s premium valuation is more deserved than ever given its head start in the weight-loss drug race, but Novo now looks surprisingly cheap.
• Possible further M&A in the space—watch Viking, GPC, Structured Therapeutics.

Quotes:

“This is exactly what you want to hear as a Pfizer shareholder…money well spent…you’re paid 6% [yield] while you wait.”
—Tim Seymour (27:49)

“Isn’t Lilly’s valuation more worth it today, seeing that…the position as number one is firmer?”
—Melissa Lee (29:12)

Timestamps:

• Weight loss drug discussion: [25:38–29:34]

Streaming & Media: Paramount Surges, Eyes on Disney

• Paramount raised job cut/cost savings targets, boosting shares; will raise Paramount+ streaming prices. CEO Ellison: “No must-haves for us; we can absolutely build but can be opportunistic.”
• Discussion that streaming consolidation is likely as “rebundling” looms.
• Disney's undervalued legacy assets and positive DTC (direct-to-consumer) momentum noted, though panelists noted chronic underperformance in the stock.

Quotes:

“Ellison apparently addressed M&A on the conference call—there are no must-haves for us…we have the balance sheet to be opportunistic.”
—Melissa Lee (43:27)

“Disney’s legacy assets are not given enough credit, enough value…But, boy, I’ve liked Disney for five years…”
—Tim Seymour (44:34)

Timestamps:

• Paramount/Disney: [43:01–44:54]

Sports Betting Integrity & DraftKings

• MLB and sportsbook partners cap single-pitch bets and exclude them from parlays after reports of betting-based cheating.
• The change is intended to stem integrity risks from “micro bets” and deter athletes from attempting to sway outcomes.
• Discussion on whether tighter rules on legal bets push activity to illegal markets.

Quotes:

“MLB says these micro bets create heightened integrity risks because they focus on one off events that can be determined by a single player…”
—Contessa Brewer (31:09)

“DraftKings’ biggest issue is the competitive balance margin profile…not terribly cheap.”
—Tim Seymour (32:37)

Timestamps:

• Sports betting segment: [30:56–33:29]

AI Infrastructure: Extreme Networks

• Interview with Ed Meyers, CEO of Extreme Networks, which positions as an enterprise AI/networking rival to Cisco and HP.
• Claims smaller size is an advantage, enabling quicker innovation and unique solutions for AI-powered networking.
• Strong reference customers: NFL stadiums, Kroger, Japanese government.
• Margin pressures discussed; Meyers insists it’s not a major issue, expects continued momentum.

Quote:

“Our difference is that we’re bringing AI to networking…we’re coming out with the very first platform for networking.”
—Ed Meyers (38:51)

“We beat out Cisco because of the differentiation of our technology…There’s an advantage to being our size and bringing out AI.”
—Ed Meyers (40:38)

Timestamps:

• Interview: [38:12–41:46]

Notable Quotes & Memorable Moments

• David Zervos on AI/Capex:
  “History says that it’s hard to pick those winners…after every single [tech wave] we have a crash.” (20:21)
• Karen Finerman on Meta:
  “It’s actually now the cheapest of the Mag 7, having been the best performer, now the worst performer.” (12:46)
• Panel Banter:
  On following the rules in “Would You Rather” segment
  “I’ll play the game the right way.” —Tim Seymour (35:14)
  “Next, I’ll play the game correctly because I’m a rule follower.” —Dan Nathan (35:25)

Timestamps for Important Segments

• Market tech rally context: 00:50–02:08
• CoreWeave earnings deep dive: 02:08–05:40; update 36:55
• Power constraints in AI infrastructure: 05:14–06:09
• Macro/jobs data discussion: 07:05–08:21
• AI trade & capex concerns: 16:42–21:19
• Retail Would You Rather: 34:14–36:33
• Weight loss pharma battles: 25:38–29:34
• Sports betting scandal: 30:56–33:29
• Extreme Networks interview: 38:12–41:46
• Paramount/Disney review: 43:01–44:54

Final Trades

• Tim Seymour: Disney
• Karen Finerman: Uber
• David Zervos: Would avoid CoreWeave on power risk
• Dan Nathan: Structure Therapeutics

Summary Takeaways

• The tech sector’s rally is underpinned by enormous capital investment, but logjams in power infrastructure and narrowing market breadth remain key risks.
• CoreWeave’s enormous backlog and exclusive AI infrastructure play are tempered by margin struggles and power delivery delays, echoing across the sector.
• Labor market softness and concerns about AI-driven job displacement could soon affect consumer spending and policy.
• In retail, Walmart remains the defensive favorite—but Target’s bombed-out valuation attracts bargain hunters.
• The pharma arms race is shifting: Lilly is rewarded for first-mover advantage; Pfizer and Novo must find ways to compete and grow.
• Market concentration in major tech players is high, but panelists expect market breadth to improve.
• Regulatory tightening in sports betting is meant to control integrity risks, but unintended consequences above and below ground must be watched.
• The AI infrastructure buildout is cleaving market winners and losers, with competition and agility more important than ever.

A lively episode brimming with actionable insights, skepticism, and strong opinions—a must recap for investors navigating the AI bull run, retail showdowns, and late-year currents in the market.